Smith Michael David 4
4 · KalVista Pharmaceuticals, Inc. · Filed May 28, 2021
Insider Transaction Report
Form 4
Smith Michael David
Sr. VP, Development
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-05-26+35,000→ 35,000 totalExercise: $25.95Exp: 2031-05-25→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests over a 4 year period: 1/48th on June 26, 2021, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.